Trials / Completed
CompletedNCT01121211
Hormonal Factors in the Treatment of Anorexia Nervosa
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are investigating whether a hormone that is naturally produced by the human body, called testosterone, can help improve weight, disordered eating, depression, and anxiety. The investigators hypothesize that testosterone will be a novel and effective endocrine-targeted therapy for patients with anorexia nervosa.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone | Testosterone 300mcg transdermal patch x 24 weeks. |
| DRUG | Placebo | Placebo transdermal patch x 24 weeks |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2016-02-01
- Completion
- 2016-02-01
- First posted
- 2010-05-12
- Last updated
- 2020-09-02
- Results posted
- 2017-04-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01121211. Inclusion in this directory is not an endorsement.